Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.

48 total trials for this combination

Showing top 10 of 48 trials

Trials

NCT ID	Title	Status	Phase
NCT02914561	Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease	COMPLETED	PHASE3
NCT03345836	A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy	COMPLETED	PHASE3
NCT03105102	A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease	ACTIVE_NOT_RECRUITING	PHASE3
NCT06430801	A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)	RECRUITING	—
NCT01369355	A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)	COMPLETED	PHASE3
NCT03104413	A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment	COMPLETED	PHASE3
NCT05242471	A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease	ACTIVE_NOT_RECRUITING	PHASE2
NCT03345823	A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433	ACTIVE_NOT_RECRUITING	PHASE3
NCT03466411	A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease	ACTIVE_NOT_RECRUITING	PHASE2/PHASE3
NCT02914600	Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease	TERMINATED	PHASE3

Related Pages

All Crohn's disease trials All trials in Vandœuvre-lès-Nancy, France